Showing results (71-80 of 336) with videos related to
Sort By:
Pageof 34
Clinical Otolaryngology and Allied Sciences|April 12, 2001
The effect of the nasal cycle on mucociliary clearanceR J Soane, A S Carney, N S Jones, et al.Pharmaceutical Research|July 1, 1990
Nasal absorption enhancers for biosynthetic human growth hormone in ratsD T O'Hagan, H Critchley, N F Farraj, et al.The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Intranasal delivery of morphineL Illum, P Watts, A N Fisher, et al.Biopharmaceutics & Drug Disposition|November 1, 1996
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic studyL Illum, S S Davis, M Pawula, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 1999
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPSP D Scholes, A G Coombes, L Illum, et al.Journal of Drug Targeting|January 1, 1997
Human serum albumin as a probe for surface conditioning--a study of the ageing effectT I Armstrong, L IllumCritical Reviews in Therapeutic Drug Carrier Systems|January 1, 1990
Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccineD T O'Hagan, L IllumBiomaterials|September 1, 1997
Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymerJ Vandorpe, E Schacht, S Dunn, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 21, 2002
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessationYu Hui Cheng, P Watts, M Hinchcliffe, et al.Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.Pageof 34